Clinical trial
Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or…
NCT00020332 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00020332 |
|---|---|
| Title | Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer |
| Official title | A Phase I/II Trial of Docetaxel Followed by Infusional Flavopiridol Over 72 Hours in Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | alvocidib, docetaxel |
| Start date | Oct 1, 2000 |
| Completion | Mar 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: